Dublin, Ireland — Nearly five years have elapsed since the onset of what many have termed the “Covid Panic,” yet the long-term effects of Ireland’s extended lockdown measures remain largely unexplored by officials. Despite pledges for a comprehensive Covid inquiry ahead of the general election, promised by former health minister Simon Harris, the expected review has not materialized, raising concerns among public health experts and the general populace alike.
Recent findings highlighted in a Eurostat report for December 2024 indicate that Ireland continues to experience a troublingly high excess mortality rate, ranking fourth worst in the European Union at 11.5%. In comparison, countries like Croatia, Bulgaria, and Latvia reported negative excess death rates, showcasing a stark contrast.
Excess mortality, as defined by Eurostat, measures the total number of deaths during a specific period against a baseline average from previous years—2016 to 2019 in this case. This metric provides insights into broader health trends across the EU by capturing all causes of death, rather than isolating specific conditions or diseases.
The persistence of high excess mortality in Ireland points to significant public health challenges. One particularly concerning aspect is the potential linkage between prolonged lockdowns and delayed medical care, especially in critical areas such as cancer screening and early intervention. A European Commission report from last month positioned Ireland second only to Denmark in new cancer diagnoses per capita within the EU.
Detailed data from 2022 highlighted a projected surge in cancer incidents, anticipating a 47% increase by 2040, much higher than the European average. This projection aligns with earlier studies suggesting substantial decreases in cancer diagnosis rates during the peak lockdown phase in 2021, attributed mainly to healthcare service disruptions and public reluctance to seek medical attention amidst the pandemic.
A comprehensive study published in The Lancet in October 2024 indicated a dramatic fall in weekly cancer diagnosis rates and a worrying statistic that 45% of individuals exhibiting cancer symptoms avoided consulting their general practitioners during the initial lockdown. Such delays and decreases in health engagements are likely contributing significantly to the observed excess mortality.
The impact of Covid-related restrictions on healthcare capacity and patient behavior has been profound. Stringent limitations during the peak of the pandemic led to a near 90% drop in the number of people seeking care for cancer symptoms by the end of the lockdown periods. This severe reduction in medical consultations and screenings is expected to lead to increased cancer-specific mortality due to delayed or missed diagnoses.
Governance and policy response to the pandemic, including the decision to impose long-term lockdowns, has come under scrutiny. Mixed messages from governmental and health authorities likely exacerbated public uncertainty and fear, deterring essential health-seeking behaviors.
Interestingly, despite the clear data on excess deaths and associated health issues, there appears to be a notable reluctance among some politicians and authorities to address or even acknowledge these issues openly. This avoidance may be driven by concerns over raising sensitive topics such as vaccine-related complications, despite the clear need for policy scrutiny and accountability.
Both the Department of Health in Ireland and the Society of Actuaries have provided insights into the methodology and challenges of measuring excess mortality. The Department monitors data from various sources and acknowledges the complexities posed by demographic changes, notably the significant increase in the elderly population, which grew by 32% from 2016 to 2024.
In conclusion, the enduring high rate of excess deaths in Ireland calls for urgent and transparent examination. Establishing a dedicated task force to investigate the root causes and implications of these mortality trends should be prioritized to inform future health policy and prevent similar outcomes in potential future health crises. Clear, accurate, and timely data dissemination, coupled with a proactive investigative approach, are essential to navigating the post-pandemic landscape and ensuring public health resilience.